Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) SHH

Currency In CNY

AD

Valuation

Market Cap41.85B
Enterprise Value47.6B
P/E Ratio13.23
PEG Ratio-1.53
Price/Sales Ratio0.44
Price/Book Ratio0.76
Enterprise/Revenue0.67
Enterprise/EBITDA12.83

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.03
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.07

Income Statement

Revenue77.45B
Revenue/Share54.91
Gross Profit11.76B
EBITDA5.07B
Net Income2.98B
Diluted EPS1.83

Balance Sheet

Total Cash0
Total Cash/Share0
Total Debt18.53B
Total Debt/Equity0.47
Current Ratio0
Book Value Per Share58.65

Price History

52-Week Change-23.8
52-Week High27.62
52-Week Low19.3
Moving Average 50 Days21.42
Moving Average 200 Days23.61

Statistics

Average Volume10.12M
Shares Outstanding1.63B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.85
Trailing Annual Dividend Yield4.07
Payout Ratio0.81
Last Split FactorN/A
Last Split DateN/A
AD